Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

References for PMC Articles for PubMed (Select 22453133)

1.

Noninvasive assessment of liver fibrosis.

Nguyen D, Talwalkar JA.

Hepatology. 2011 Jun;53(6):2107-10. doi: 10.1002/hep.24401. No abstract available.

PMID:
21547935
2.

Clinical syndromes and consequences of antiretroviral-related hepatotoxicity.

Núñez M.

Hepatology. 2010 Sep;52(3):1143-55. doi: 10.1002/hep.23716. Review.

PMID:
20812358
3.

Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance.

Blanco F, Barreiro P, Ryan P, Vispo E, Martín-Carbonero L, Tuma P, Labarga P, Medrano J, González-Lahoz J, Soriano V.

J Viral Hepat. 2011 Jan;18(1):11-6. doi: 10.1111/j.1365-2893.2009.01261.x.

PMID:
20088890
4.

Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.

Kovari H, Ledergerber B, Battegay M, Rauch A, Hirschel B, Foguena AK, Vernazza P, Bernasconi E, Mueller NJ, Weber R.

Clin Infect Dis. 2010 Feb 15;50(4):502-11. doi: 10.1086/649922.

5.

Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.

Castéra L, Sebastiani G, Le Bail B, de Lédinghen V, Couzigou P, Alberti A.

J Hepatol. 2010 Feb;52(2):191-8. doi: 10.1016/j.jhep.2009.11.008. Epub 2009 Nov 24.

PMID:
20006397
6.

Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients.

Pineda JA, González J, Ortega E, Tural C, Macías J, Griffa L, Burgos A; Grafihco Study Team.

J Viral Hepat. 2010 Oct;17(10):714-9. doi: 10.1111/j.1365-2893.2009.01229.x.

PMID:
20002560
7.

Diagnosis, management and prevention of drug-induced liver injury.

Verma S, Kaplowitz N.

Gut. 2009 Nov;58(11):1555-64. doi: 10.1136/gut.2008.163675.

PMID:
19834119
8.

Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus.

Macías J, Berenguer J, Japón MA, Girón JA, Rivero A, López-Cortés LF, Moreno A, González-Serrano M, Iribarren JA, Ortega E, Miralles P, Mira JA, Pineda JA.

Hepatology. 2009 Oct;50(4):1056-63. doi: 10.1002/hep.23136.

PMID:
19670415
9.

Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers.

Poynard T, Ingiliz P, Elkrief L, Munteanu M, Lebray P, Morra R, Messous D, Bismut FI, Roulot D, Benhamou Y, Thabut D, Ratziu V.

PLoS One. 2008;3(12):e3857. doi: 10.1371/journal.pone.0003857. Epub 2008 Dec 4.

10.

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression.

Thein HH, Yi Q, Dore GJ, Krahn MD.

Hepatology. 2008 Aug;48(2):418-31. doi: 10.1002/hep.22375. Review.

PMID:
18563841
11.

Performance of transient elastography for the staging of liver fibrosis: a meta-analysis.

Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Herrmann E.

Gastroenterology. 2008 Apr;134(4):960-74. doi: 10.1053/j.gastro.2008.01.034. Epub 2008 Jan 18. Review.

PMID:
18395077
12.

Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.

Cacoub P, Carrat F, Bédossa P, Lambert J, Pénaranda G, Perronne C, Pol S, Halfon P.

J Hepatol. 2008 May;48(5):765-73. doi: 10.1016/j.jhep.2008.01.025. Epub 2008 Feb 14.

PMID:
18314219
13.

Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study.

Rodríguez-Torres M, Govindarajan S, Solá R, Clumeck N, Lissen E, Pessôa M, Buggisch P, Main J, Depamphilis J, Dieterich DT.

J Hepatol. 2008 May;48(5):756-64. doi: 10.1016/j.jhep.2008.01.015. Epub 2008 Feb 7.

PMID:
18314217
14.

Systematic review and meta-analysis of the diagnostic accuracy of fibrosis marker panels in patients with HIV/hepatitis C coinfection.

Shaheen AA, Myers RP.

HIV Clin Trials. 2008 Jan-Feb;9(1):43-51. doi: 10.1310/hct0901-43. Review.

PMID:
18215981
15.

Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy.

Lactic Acidosis International Study Group.

AIDS. 2007 Nov 30;21(18):2455-64. Review.

PMID:
18025882
16.

The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection.

Vergara S, Macías J, Rivero A, Gutiérrez-Valencia A, González-Serrano M, Merino D, Ríos MJ, García-García JA, Camacho A, López-Cortés L, Ruiz J, de la Torre J, Viciana P, Pineda JA; Grupo para el Estudio de las Hepatitis Viricas de la SAEI.

Clin Infect Dis. 2007 Oct 15;45(8):969-74. Epub 2007 Sep 11.

17.

FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy.

Shaheen AA, Wan AF, Myers RP.

Am J Gastroenterol. 2007 Nov;102(11):2589-600. Epub 2007 Sep 10. Review.

PMID:
17850410
18.

Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.

Weber R, Sabin CA, Friis-Møller N, Reiss P, El-Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B, Calvo G, Monforte Ad, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD.

Arch Intern Med. 2006 Aug 14-28;166(15):1632-41.

PMID:
16908797
19.

Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.

Barreiro P, Martín-Carbonero L, Núñez M, Rivas P, Morente A, Simarro N, Labarga P, González-Lahoz J, Soriano V.

Clin Infect Dis. 2006 Apr 1;42(7):1032-9. Epub 2006 Feb 21.

20.

Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients.

de Lédinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, Dhumeaux D, Beaugrand M.

J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):175-9.

PMID:
16394849
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk